微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 27.23% | -3.68% | 2.17% | 22/54 | 73.39% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 26.65% | -9.82% | 2.31% | 46/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 26.05% | -14.04% | -3.22% | 46/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
| 2023-12-31 | 26.92% | -19.97% | -4.79% | 46/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 28.27% | -14.84% | -4.34% | 44/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 29.55% | -11.66% | -2.47% | 44/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 30.3% | -10.01% | -9.89% | 45/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 33.63% | -31.42% | 1.3% | 44/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 33.2% | -38.54% | -0.76% | 43/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 33.45% | -42.62% | -0.65% | 44/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 33.67% | -17.77% | -31.33% | 39/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 49.04% | 25.77% | -9.22% | 40/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 54.01% | 34.97% | -7.36% | 37/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 58.3% | 51.55% | 42.38% | 36/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 40.95% | 10.42% | 5.03% | 34/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 38.99% | -7.27% | -2.58% | 43/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 40.02% | -4.58% | 4.02% | 33/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 38.47% | -6.55% | 3.74% | 40/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 37.09% | -7% | -11.8% | 30/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 42.05% | -23.23% | 0.25% | 39/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 41.94% | -26.25% | 1.87% | 25/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 41.17% | -30.46% | 3.24% | 24/54 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 39.88% | -27.45% | -27.19% | 22/54 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 54.77% | -30.27% | -3.7% | 30/54 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 56.87% | -35.36% | -3.94% | 18/54 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 59.2% | -35.84% | 7.71% | 19/54 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 54.96% | -41.42% | -30.02% | 16/54 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 78.54% | -14.72% | -10.72% | 15/54 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 87.98% | -5.12% | -4.64% | 5/54 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 92.26% | 1.37% | -1.66% | 2/54 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 93.82% | 0.71% | 1.87% | 2/54 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 92.1% | 14.97% | -0.67% | 4/54 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 92.73% | 20.94% | 1.88% | 2/54 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 91.01% | 28.51% | -2.31% | 3/54 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 93.16% | 55.39% | 16.29% | 2/54 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 80.11% | 30.91% | 4.48% | 8/54 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 76.67% | 24.71% | 8.27% | 5/54 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 70.82% | 14.93% | 18.12% | 8/54 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 59.96% | 3.24% | -2.03% | 10/54 | 57.69% | 我武生物 | 95.59% | 行业排名> |
| 2014-12-31 | 61.2% | 1.13% | -0.47% | 18/54 | 63.59% | 欧林生物 | 99.52% | 行业排名> |
| 2014-09-30 | 61.48% | 7.11% | -0.22% | 10/54 | 58.74% | 我武生物 | 95.83% | 行业排名> |
| 2014-06-30 | 61.62% | 10.57% | 6.11% | 7/54 | 57.05% | 我武生物 | 95.96% | 行业排名> |
| 2014-03-31 | 58.07% | 17.96% | -4.03% | 10/54 | 57.57% | 我武生物 | 96.38% | 行业排名> |